Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Pharmaceutics
|
February 27, 2026
Impact of Neonatal Fc Receptor on Transferrin Receptor Antibody Fusion Protein Pharmacokinetics
Adenike Oyegbesan, Nataraj Jagadeesan, Devaraj V Chandrashekar, et al.
International Journal of Molecular Sciences
|
June 10, 2023
Alcohol as a Modifiable Risk Factor for Alzheimer's Disease-Evidence from Experimental Studies
Devaraj V Chandrashekar, Ross A Steinberg, Derick Han, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 24, 2025
Basic Science and Pathogenesis
Brian Carson, Josephine Chu, Devaraj V Chandrashekar, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 23, 2025
Basic Science and Pathogenesis
Josephine Chu, Ross A Steinberg, Brian Carson, et al.
Journal of Translational Medicine
|
March 19, 2024
Modulation of hippocampal protein expression by a brain penetrant biologic TNF-α inhibitor in the 3xTg Alzheimer's disease mice
Nataraj Jagadeesan, G Chuli Roules, Devaraj V Chandrashekar, et al.
Drug Research
|
June 1, 2017
Sensitive LC-MS/MS Method for the Simultaneous Determination of Bendamustine and its Active Metabolite, γ-Hydroxybendamustine in Small Volume Mice and Dog Plasma and its Application to a Pharmacokinetic Study in Mice and Dogs
Devaraj V Chandrashekar, Ponnayyan S Suresh, Rajnish Kumar, et al.
International Journal of Pharmaceutics: X
|
January 6, 2026
Longitudinal pharmacokinetic and safety studies of an antibody-erythropoietin fusion protein for Alzheimer's disease
Rudy Chang, Devaraj V Chandrashekar, G Chuli Roules, et al.
Research Square
|
June 30, 2025
Longitudinal pharmacokinetic and safety studies for dose optimization of a brain- penetrating erythropoietin for Alzheimer's disease
Rudy Chang, Devaraj V Chandrashekar, G Chuli Roules, et al.
Biomedical Chromatography : BMC
|
December 29, 2019
High-throughput screening assay for the quantification of Cer d18:1/16:0, d18:1/24:0, d18:1/24:1, d18:1/18:0, d18:1/14:0, d18:1/20:0, and d18:1/22:0 in HepG2 cells using RapidFire mass spectrometry
Sreekanth Dittakavi, Lavanya Mahadevan, Devaraj V Chandrashekar, et al.
Pharmaceutics
|
October 27, 2022
Efficacy and Safety of a Brain-Penetrant Biologic TNF-α Inhibitor in Aged APP/PS1 Mice
Weijun Ou, Yuu Ohno, Joshua Yang, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Pharmaceutics
|
February 27, 2026
Impact of Neonatal Fc Receptor on Transferrin Receptor Antibody Fusion Protein Pharmacokinetics
Adenike Oyegbesan, Nataraj Jagadeesan, Devaraj V Chandrashekar, et al.
International Journal of Molecular Sciences
|
June 10, 2023
Alcohol as a Modifiable Risk Factor for Alzheimer's Disease-Evidence from Experimental Studies
Devaraj V Chandrashekar, Ross A Steinberg, Derick Han, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 24, 2025
Basic Science and Pathogenesis
Brian Carson, Josephine Chu, Devaraj V Chandrashekar, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 23, 2025
Basic Science and Pathogenesis
Josephine Chu, Ross A Steinberg, Brian Carson, et al.
Journal of Translational Medicine
|
March 19, 2024
Modulation of hippocampal protein expression by a brain penetrant biologic TNF-α inhibitor in the 3xTg Alzheimer's disease mice
Nataraj Jagadeesan, G Chuli Roules, Devaraj V Chandrashekar, et al.
Drug Research
|
June 1, 2017
Sensitive LC-MS/MS Method for the Simultaneous Determination of Bendamustine and its Active Metabolite, γ-Hydroxybendamustine in Small Volume Mice and Dog Plasma and its Application to a Pharmacokinetic Study in Mice and Dogs
Devaraj V Chandrashekar, Ponnayyan S Suresh, Rajnish Kumar, et al.
International Journal of Pharmaceutics: X
|
January 6, 2026
Longitudinal pharmacokinetic and safety studies of an antibody-erythropoietin fusion protein for Alzheimer's disease
Rudy Chang, Devaraj V Chandrashekar, G Chuli Roules, et al.
Research Square
|
June 30, 2025
Longitudinal pharmacokinetic and safety studies for dose optimization of a brain- penetrating erythropoietin for Alzheimer's disease
Rudy Chang, Devaraj V Chandrashekar, G Chuli Roules, et al.
Biomedical Chromatography : BMC
|
December 29, 2019
High-throughput screening assay for the quantification of Cer d18:1/16:0, d18:1/24:0, d18:1/24:1, d18:1/18:0, d18:1/14:0, d18:1/20:0, and d18:1/22:0 in HepG2 cells using RapidFire mass spectrometry
Sreekanth Dittakavi, Lavanya Mahadevan, Devaraj V Chandrashekar, et al.
Pharmaceutics
|
October 27, 2022
Efficacy and Safety of a Brain-Penetrant Biologic TNF-α Inhibitor in Aged APP/PS1 Mice
Weijun Ou, Yuu Ohno, Joshua Yang, et al.
Page
of 2